Novel c-MYC target genes mediate differential effects on cell proliferation and migration

Related Experiment Video

Updated: Jul 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

David Cappellen1, Thomas Schlange, Matthieu Bauer

  • 1Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, CH-4058 Basel, Switzerland. cappellen@igr.fr

EMBO Reports
|December 13, 2006
PubMed

Insights

The MYC protein

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The roles of MYC proteins in development and cancer are known, but the specific genes they regulate are not fully understood.
  • MYC proteins are crucial regulators of cell growth, proliferation, and metabolism.

Purpose of the Study:

  • To identify novel c-MYC target genes in breast and cervix carcinoma cell lines.
  • To investigate how c-MYC regulates cell metabolism, proliferation, and migration.
  • To understand the cellular-context-dependent functions of c-MYC.

Main Methods:

  • Small interfering RNA (siRNA)-mediated knockdown of c-MYC in carcinoma cell lines.
  • Genomic and phenotypic analyses to identify c-MYC target genes and their functional impact.
  • Analysis of WNT signaling pathway and CCL5/RANTES gene expression.

Main Results:

  • c-MYC independently controls metabolism and proliferation, and differentially affects cell migration.
  • New c-MYC target genes were identified, with selective regulation correlating to phenotypic changes.
  • Upregulation of WNT signaling contributes to c-MYC's pro-mitogenic effects, while repression of CCL5/RANTES mediates anti-migratory effects in specific contexts.

Conclusions:

  • c-MYC's functions are highly dependent on the cellular context.
  • Specific target gene regulation explains the diverse roles of c-MYC in cancer cell behavior.
  • Understanding context-specific MYC targets is crucial for developing targeted cancer therapies.

More Related Videos

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...